Perceptive Advisors
Kunal Kandimalla currently serves as Vice President of Public and Private Biotech Investments at Perceptive Advisors since April 2018. Prior experience includes a consultant role in Global Rare Disease Hematology at Sanofi Genzyme in 2017, corporate strategy at Novartis in 2016, and business development and operations at Agios Pharmaceuticals from January 2014 to July 2015. Kunal began a career in life sciences strategy as a consultant at Putnam Associates from September 2010 to January 2014. Academic qualifications include an M.B.A. in Healthcare Management, Finance, and Entrepreneurial Management from The Wharton School (2015-2017) and a B.A. in Economics with Honors, Healthcare Management, and Biological Basis of Behavior from the University of Pennsylvania (2006-2010). Kunal is a graduate of Grapevine High School (2002-2006).
This person is not in any teams
Perceptive Advisors
Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare. The information presented in this page is included to enable professional networking by Perceptive Advisor’s employees and should not be used for any other purpose. As such, Perceptive Advisor’s use of LinkedIn is not an offer to, or solicitation of, any potential clients or investors for the provision of investment management, advisory or any other related services. No information posted by Perceptive Advisors should be construed as investment advice, or as an offer to sell, or a solicitation of an offer to buy, any security or other instrument.